Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. 1970

V A Alabaster, and Y S Bakhle

1. Rat isolated lungs perfused via the pulmonary artery with Krebs solution removed 92% of the 5-hydroxytryptamine (5-HT) infused through it. This degree of removal was independent of concentration in the range from 5 to 100 g/ml.2. The removal of 5-HT by the lungs was inhibited by amitriptyline and desmethylimipramine (10(-6)-10(-5)M).3. The monoamine oxidase inhibitors, mebanazine and iproniazid (10(-6)-10(-5)M), inhibited the initial removal slightly, but their main effect was to preserve the 5-HT taken up and this 5-HT slowly reappeared in the effluent from the lungs. Tranylcypromine (5 x 10(-7)-10(-6)M) showed a combination of amitriptyline-like and mebanazine-like effects on the 5-HT removal in rat lung.4. Experiments with (3)H-5-HT showed that although under normal conditions only 10% of the radioactivity appeared in the lung effluent as 5-HT within the first 5 min, the rest of radioactivity administered could be recovered in the effluent over 50 min as a metabolite, probably 5-hydroxyindoleacetic acid.5. The following amines were without effect on the removal of 5-HT by rat lungs: noradrenaline (6 x 10(-7)M), normetanephrine (5 x 10(-6)M), metaraminol (10(-6)M), reserpine (10(-6)-10(-5)M) and phenoxybenzamine (10(-5)M).6. We conclude that the removal of 5-HT by rat lungs involves a process of uptake and metabolism rather than one of uptake and storage, but this process is not the catecholamine Uptake(2). The cells involved in this process might be either capillary endothelial cells or septal cells.

UI MeSH Term Description Entries
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V A Alabaster, and Y S Bakhle
January 1991, Acta physiologica Hungarica,
V A Alabaster, and Y S Bakhle
September 1981, Acta pharmacologica et toxicologica,
V A Alabaster, and Y S Bakhle
January 1958, Comptes rendus des seances de la Societe de biologie et de ses filiales,
V A Alabaster, and Y S Bakhle
November 1972, The Journal of pharmacology and experimental therapeutics,
V A Alabaster, and Y S Bakhle
February 1959, The American journal of physiology,
V A Alabaster, and Y S Bakhle
October 1987, Canadian journal of physiology and pharmacology,
V A Alabaster, and Y S Bakhle
March 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!